← Back to Analyst Consensus 
GDTC Buy
CytoMed Therapeutics Ltd
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 10, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $5 | 54% |
| Jun 11, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $5 | 54% |
| Dec 4, 2023 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $5 | 54% |
| Jul 21, 2023 | Benchmark | initiate | — → Speculative Buy | $5 | 54% |
Price Target Trend
Sep 18, 2026 Latest: $4.16 Oct 24, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days